NCT01041287 - Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Hypertension

Interventions

DRUG

Nebivolol

Nebivolol 5 mg PO qday for 2 weeks, titrated up to Nebivolol 10 mg PO qday if BP is \>125/80 for the 2 more weeks, and then titrated up to Nebivolol 20 mg PO qday if BP is \>125/80 for the remaining 8 weeks

DRUG

Metoprolol succinate

Metoprolol 50 mg PO qday for 2 weeks, titrated up to Metoprolol 100 mg PO qday if BP is \>125/80 for the 2 more weeks, and then titrated up to Metoprolol 200 mg PO qday if BP is \>125/80 for the remaining 8 weeks

Trial Locations (1)

30322

Emory University, Atlanta